枫蓼肠胃康片治疗急性胃肠炎临床试验小结Clinical testing summery of Fengliao Changweikang tablets in the treatment of acute enterogastritis
蔡越冬,徐雯,梁康成
Cai Yuedong;Xu Wen;Liang Kangcheng(Guangzhou baiyunshan pharmaceutical factory of TCM;
摘要(Abstract)：
目的 客观评价枫蓼肠胃康片治疗急性胃肠炎的临床疗效及其安全性。方法 将 1 2 0例急性胃肠炎患者分成两组 ,其中 70例用枫蓼肠胃康片治疗 ,另设 50例为对照组 ,观察比较临床疗效。结果 治疗组与对照组的总有效率分别为 94.3 %、88% ,两组比较有显著性意义 (P <0 .0 5)。结论 枫蓼肠胃康片治疗急性胃肠炎疗效确切 ,用药安全 ,疗效优于对照药
Objective: To access the clinical effect of Fengliao Changwei Kang(FLCWK)in treating acute enteroastritis(AE)and evaluate its safety. Methods One hundred and twenty patients of AE were divided into two groups. Seventy of them were allocated to FLCWKP treatment group and the other fifty were as control group. Results The total effective rate of treatment group and control group were 94.3% and 88% respectively. The difference between two groups was obvious. Conclusion FLCWK is effective and safety for AE. The effect of FLCWK for AE is better than that of control group.
关键词(KeyWords)：
枫蓼肠胃康片;急性胃肠炎;临床
fengliao changweikang tablet, acute enterogastritis , clinical
基金项目(Foundation):
作者(Authors):
蔡越冬,徐雯,梁康成
Cai Yuedong;Xu Wen;Liang Kangcheng(Guangzhou baiyunshan pharmaceutical factory of TCM;